[Federal Register: August 15, 2006 (Volume 71, Number 157)]
[Notices]
[Page 46921]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr15au06-55]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on April 27, 2006, Dade Behring,
Inc., Regulatory Affairs, Quality Systems, 20400 Mariani Avenue,
Cupertino, California 95014, made application by renewal to the Drug
Enforcement Administration (DEA) for registration as a bulk
manufacturer of the basic classes of controlled substances listed in
Schedule I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)............... I
Benzoylecgonine (9180)..................... II
Morphine (9300)............................ II
------------------------------------------------------------------------
The company plans to produce the listed controlled substances in
bulk products to be used in the manufacture of reagents and drug
calibrator/controls for DEA exempt products.
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
may be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative/ODL; or any being sent via express mail should be sent
to DEA Headquarters, Attention: DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must
be filed no later than October 16, 2006.
Dated: August 7, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-13327 Filed 8-14-06; 8:45 am]
BILLING CODE 4410-09-P